White House 100% Tariffs to Force MFN Drug Pricing and US Manufacturing
White House unveiled 100% tariffs last week on brand-name imported drugs from drugmakers not negotiating MFN prices and U.S. manufacturing commitments. Exceptions apply, advancing trade strategy on pharma pricing and domestic production.






